Disclosure of individual surgeon's performance rates during informed consent: ethical and epistemological considerations.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMC 1877054)

Published in Ann Surg on April 01, 2007

Authors

Ingrid Burger1, Kathryn Schill, Steven Goodman

Author Affiliations

1: Phoebe R. Berman Bioethics Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. iburger@jhsph.edu

Articles cited by this

Surgeon volume and operative mortality in the United States. N Engl J Med (2003) 16.97

The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg (1998) 9.77

The public release of performance data: what do we expect to gain? A review of the evidence. JAMA (2000) 9.57

The unintended consequences of publicly reporting quality information. JAMA (2005) 6.55

(Almost) everything you ever wanted to know about informed consent. [Review of: Faden, RR and Beauchamp, TL. A history and theory of informed concsent. New York and Oxford: Oxford University Press, 1986]. Med Humanit Rev (1987) 5.53

Influence of cardiac-surgery performance reports on referral practices and access to care. A survey of cardiovascular specialists. N Engl J Med (1996) 5.32

Cardiac surgery report cards: comprehensive review and statistical critique. Ann Thorac Surg (2001) 4.26

Use of public performance reports: a survey of patients undergoing cardiac surgery. JAMA (1998) 4.16

The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med (2003) 4.01

Adult open heart surgery in New York State. An analysis of risk factors and hospital mortality rates. JAMA (1990) 3.09

Racial profiling: the unintended consequences of coronary artery bypass graft report cards. Circulation (2005) 2.54

Benefits and hazards of reporting medical outcomes publicly. N Engl J Med (1996) 2.52

The decline in coronary artery bypass graft surgery mortality in New York State. The role of surgeon volume. JAMA (1995) 2.44

Will quality report cards help consumers? Health Aff (Millwood) (1997) 2.24

The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons. Ann Thorac Surg (2000) 1.85

The legacy of Bristol: public disclosure of individual surgeons' results. BMJ (2004) 1.82

New York State's Cardiac Surgery Reporting System: four years later. Ann Thorac Surg (1994) 1.78

How do elderly patients decide where to go for major surgery? Telephone interview survey. BMJ (2005) 1.58

Selection of a cardiac surgery provider in the managed care era. J Thorac Cardiovasc Surg (2000) 1.58

Probability at the bedside: the knowing of chances or the chances of knowing? Ann Intern Med (1999) 1.46

A comparison of a Bayesian vs. a frequentist method for profiling hospital performance. J Eval Clin Pract (2001) 1.29

Assessment of coronary artery bypass graft surgery performance in New York. Is there a bias against taking high-risk patients? Med Care (1997) 1.16

Subtracting insult from injury: addressing cultural expectations in the disclosure of medical error. J Med Ethics (2005) 1.16

A comparison of Bayesian methods for profiling hospital performance. Med Decis Making (2002) 1.06

Is risk-adjustor selection more important than statistical approach for provider profiling? Asthma as an example. Med Decis Making (2005) 0.96

Informed consent and surgeons' performance. J Med Philos (2004) 0.80

Articles by these authors

Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med (2008) 4.58

Averting biodiversity collapse in tropical forest protected areas. Nature (2012) 4.46

Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila) (2010) 1.68

High-resolution scintimammography: a pilot study. J Nucl Med (2002) 1.66

Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res (2003) 1.65

Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res (2008) 1.62

Ethics: Moral issues of human-non-human primate neural grafting. Science (2005) 1.35

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. Transfus Med Rev (2002) 1.16

Metabias: a challenge for comparative effectiveness research. Ann Intern Med (2011) 0.93

Why most published research findings are false: problems in the analysis. PLoS Med (2007) 0.91

Bias and trials stopped early for benefit. JAMA (2010) 0.87

Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. J Rheumatol (2006) 0.85

Beyond the usual prediction accuracy metrics: reporting results for clinical decision making. Ann Intern Med (2012) 0.85

Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors. Clin Cancer Res (2004) 0.83

Diastolic blood pressure levels and ischemic stroke incidence in older adults with white matter lesions. J Gerontol A Biol Sci Med Sci (2010) 0.79

All that glitters isn't gold: a survey on acknowledgment of limitations in biomedical studies. PLoS One (2013) 0.75

Reanalysis of survival of OSCAR winners. Ann Intern Med (2006) 0.75

The future of clinical trials: A panel discussion. Stat Med (2012) 0.75

The long and creative arm of the drug industry. Lancet (2005) 0.75

I dedicate this issue of EBM to Professor Huan-Yao Lei. Exp Biol Med (Maywood) (2012) 0.75

Two new eimerians (Apicomplexa) from insectivorous mammals in Madagascar. J Parasitol (2010) 0.75